Mitigation of endometriosis using regenerative cerium oxide nanoparticles
article
OA: green
CC0
⤵ 15 in-corpus citations
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (45)
- Angiongenesis: a new theory for endometriosis via openalex
- Antiangiogenic therapies in endometriosis via openalex
- Are aromatase inhibitors effective in endometriosis treatment? via openalex
- Epidemiology of Endometriosis: via openalex
- Hysterectomy for treatment of pain associated with endometriosis via openalex
- Intraperitoneal inflammation decreases endometriosis in a mouse model via openalex
- Mechanistic and Therapeutic Implications of Angiogenesis in Endometriosis via openalex
- Nonhuman Primate Models for Translational Research in Endometriosis via openalex
- Novel Therapies Targeting Endometriosis via openalex
- Oxidative stress and endometriosis via openalex
- Oxidative stress may be a piece in the endometriosis puzzle via openalex
- The role of the oxidative-stress in the endometriosis-related infertility via openalex
- Women with endometriosis improved their peripheral antioxidant markers after the application of a high antioxidant diet via openalex
- W2022556212 via openalex
- W2037822353 via openalex
- W2042127587 via openalex
- W2049011008 via openalex
- W2051370773 via openalex
- W2058963501 via openalex
- W2060393076 via openalex
- W2069554279 via openalex
- W2097016322 via openalex
- W2116197104 via openalex
- W2126913802 via openalex
- W2128242634 via openalex
- W2130897794 via openalex
- W2132435301 via openalex
- W2132577372 via openalex
- W2146007516 via openalex
- W6607895445 via openalex
- W6635112832 via openalex
- W106849888 via openalex
- W7073564619 via openalex
- W195635648 via openalex
- W654910966 via openalex
- W1590457525 via openalex
- W1981837426 via openalex
- W1985959551 via openalex
- W1989057467 via openalex
- W1991456351 via openalex
- W1991728953 via openalex
- W2007873527 via openalex
- W2011562222 via openalex
- W2017028221 via openalex
- W2020177568 via openalex
Cited by (15)
- Non-invasive blood tests for earlier diagnosis and treatment of endometriosis 2025
- Ethyl Pyruvate as a Potential Therapeutic Agent for Endometriosis: A Perspective 2025
- AQbD-guided development of a green RP-HPLC method for dual drug quantification in lipid–polymer hybrid nanoparticles for endometriosis therapy 2025
- Emerging strategies for the treatment of endometriosis 2024
- Emerging Trends in Nanotechnology for Endometriosis: Diagnosis to Therapy 2024
- Nanotechnologies for the detection and treatment of endometriosis 2023
- Applications of nanomaterials in endometriosis treatment 2023
- Effect of PLGA Nanoparticle-Mediated Delivery of miRNA 503 on The Apoptosis of Ovarian Endometriosis Cells. 2022
- Naringenin ameliorates progression of endometriosis by modulating Nrf2/Keap1/HO1 axis and inducing apoptosis in rats 2019
- Captação de nanopartícula lipídica marcada radioativamente por receptores de LDL em membrana celular de focos de endometriose 2018
- Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies 2018
- The Role of Antioxidant Supplementation in Endometriosis Therapy 2017
- Antioxidants in Reproductive Health and Fertility 2017
- Drug delivery for the treatment of endometriosis and uterine fibroids 2017
- 1H NMR Based Targeted Metabolite Profiling for Understanding the Complex Relationship Connecting Oxidative Stress with Endometriosis 2013
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:16:04.919516+00:00
License: CC0
· commercial use OK